EVP, Chief Technical Officer
Sat, Mar 1, 2025
Mar 1
received an award in NTLA
45,714 shares @ $0.00
New position
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NTLAIntellia Therapeutics, Inc.
Health CareDiagnostics & Research
1D0.00%
1W+8.28%
1M+17.05%
3M-6.55%
6M—
1Y—